GlaxoSmithKline discloses bribery inquiries
British drugmaker GlaxoSmithKline is looking into allegations of bribery within its operations in Jordan and Lebanon.
On Monday, the BBC reported that GlaxoSmithKline PLC is involved in a bribery investigation in Poland, where a sales representative allegedly paid doctors to prescribe the company's asthma drug Seretide. The company said it learned of the allegations in 2011 and found evidence of inappropriate communications by an employee. It says that employee was disciplined.
The company is dealing with a corruption investigation in China and is looking into alleged bribery in Iraq.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Pittsburgh Brewing tries to reconnect with region, return to glory days
- Hiring in shale industry shifts to skilled workers
- EPA hearings to bring coal debate to Pittsburgh streets
- Stocks end with little change as investors await Fed moves, jobs report
- Dollar Tree set to spend $8.5B on Family Dollar
- FAA proposes $12M safety fine against Southwest
- Construction of $500M power plant in South Huntingdon stalled
- Central Blood Bank parent in merger talks with Florida system
- Vending machines aren’t just for potato chips
- Groups stand against ‘sub-minimum’ wage for workers with disabilities
- Congress may crimp offshore merger tax relief